Why does administering a beta-1 adrenergic receptor antagonist to a patient with heart failure reduce cardiac output?

💡 Explanation

Beta-1 antagonists block norepinephrine's action on the heart, causing decreased heart rate and reduced myocardial contractility via impaired cAMP signaling; because of this reduced workload, cardiac output is diminished. Therefore, B is correct, rather than A, C, or D, which would increase cardiac output.

• If a pathogen expresses surface antigens nearly identical to a healthy cardiac protein, which consequence follows?
• If a genetically engineered mouse lacks functional MHC class II molecules, which consequence follows regarding its adaptive immune response to a novel bacterial infection?
• Which failure mode becomes likely when antibiotic concentrations fluctuate within a biofilm due to interrupted intravenous administration?
• A researcher investigates neurodegenerative disease protein aggregates in brain tissue. Why does ubiquitin-proteasome system impairment increase the risk of pathological aggregate accumulation?
• A drug aims to inhibit EGFR (Epidermal Growth Factor Receptor) in lung cancer cells. If this drug's delivery is inconsistent, which consequence follows regarding the cancer cell cycle?
• Why does tolerance to opioids, leading to increased dosage requirements in pain management, develop within the neural circuit?